Nektar Therapeutics - Common Stock (NQ: NKTR )
0.9826
+0.0908
(+10.18%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
All News about Nektar Therapeutics - Common Stock
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_5379.jpeg?width=1200&height=800&fit=crop)
![](/next-assets/images/schema-image-default.png)
Analyst Ratings for Nektar Therapeutics
March 06, 2023
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_4746.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/06/image-tesla4.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_3659.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Tuesday
February 28, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/02/24/image41.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/02/24/image21.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_3483.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Friday's Intraday Session
February 24, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/02/24/image37.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4985.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For February 24, 2023
February 24, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/02/24/image33_0.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/01/shiftpixy-pixy-1600.png)
![](https://investorplace.com/wp-content/uploads/2023/02/shutterstock_1212299986.jpg)
![](https://investorplace.com/wp-content/uploads/2020/07/medicine-1.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/02/24/nktr_logo_light__71940bfa7111d538c8484c82bb6303ed.png?width=1200&height=800&fit=crop)
Why Nektar Therapeutics Stock Is Plunging Today
February 24, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_3444.jpeg?width=1200&height=800&fit=crop)
12 Health Care Stocks Moving In Friday's Pre-Market Session
February 24, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/02/24/image-beyond_meat.png?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/05/wall-street-morning.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/02/24/share_market_1_photo_by_gsign76_on_shutterstock.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/02/24/image20.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20230201005688/en/1702546/5/GPM_Logo_Color.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_22567.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_24058.jpeg?width=1200&height=800&fit=crop)
Stocks That Hit 52-Week Lows On Friday
December 23, 2022
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
November 29, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/21/logo_light__cf5a9515433d3224f1809e9207e10fd6.png?width=1200&height=800&fit=crop)
Analyst Says IO Biotech's Cancer Treatment Approach 'Differentiated'
November 21, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/11/14/shutterstock_252511228.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/10/07/aapharma_5.png?width=1200&height=800&fit=crop)
PureTech Health Confirms 'Possible' Merger With Nektar Therapeutics
October 07, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_2690.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/analyst_ratings_image_24473.jpeg?width=1200&height=800&fit=crop)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free